Full text
Earnings transcript
Read the complete earnings call transcript.
IEX
IDEX Corporation
$222.14
3.55
(1.62%)
| Exchange: | NYSE |
| Market Cap: | 16.442B |
| Shares Outstanding: | 146.104M |
Delayed data
About The Company
| Sector: | Industrials | |||||
| Industry: | Industrial – Machinery | |||||
| CEO: | Eric D. Ashleman | |||||
| Full Time Employees: | 9000 | |||||
| Address: |
| |||||
| Website: | https://www.idexcorp.com |
IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 3,273,900 | 3,268,800 | 3,457,500 |
| Gross Profit | 1,622,800 | 1,516,700 | 1,538,800 |
| EBITDA | 964,100 | 859,400 | 903,500 |
| Operating Income | 750,700 | 696,900 | 720,000 |
| Net Income | 596,100 | 505,000 | 483,200 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 5,865,200 | 6,745,300 | 6,927,000 |
| Total Liabilities | 2,324,000 | 2,951,200 | 2,900,800 |
| Total Stockholders Equity | 3,541,400 | 3,794,700 | 4,027,500 |
| Total Debt | 1,445,800 | 1,960,200 | 700 |
| Cash and Cash Equivalents | 534,300 | 620,800 | 580,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 716,700 | 668,100 | 680,400 |
| Capital Expenditure | -89,900 | -65,100 | -63,600 |
| Free Cash Flow | 626,800 | 603,000 | 616,800 |
| Net Income | 595,600 | 504,600 | 482,500 |
| Net Change in Cash | 104,100 | 104,600 | -53,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 4,300,953.308 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 4,392,701.168 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 4,342,000 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 1,174,361.371 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 1,199,412.827 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 1,185,569.037 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 856,795.790 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 880,623.722 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 867,456.011 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 937,272.431 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 957,266.310 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 946,217.409 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 11.520 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 11.690 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 11.380 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 5 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Financial Performance: IEX demonstrates consistent revenue growth and positive net income trends over recent years, as reflected in the Income Statements data. Strong operating cash flow and free cash flow figures from the Cash Flow Statements indicate robust liquidity and operational efficiency.
- Favorable Valuation Metrics: The current price-to-earnings (P/E) ratio and price-to-sales (P/S) ratio from Key Metrics suggest IEX is reasonably valued compared to industry averages, providing a stable investment profile. Forward P/E ratios indicate potential for sustained investor confidence based on analyst estimates.
- Strong Balance Sheet: Data from the Balance Sheet shows a healthy level of cash and cash equivalents alongside manageable total liabilities, with a reasonable debt-to-equity ratio from Key Metrics, reflecting financial stability.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates IEX intrinsic value between $116.90 – $167.12 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about IEX valuation
Is IDEX Corporation (IEX) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for IDEX Corporation (IEX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is IEX a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether IEX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is IEX’s P/E ratio?
You can see IEX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for IEX?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is IEX a good long-term investment?
Whether IEX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
IEX
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
1.62
Trading Metrics:
| Open: | 220.65 | Previous Close: | 218.59 | |
| Day Low: | 217.67 | Day High: | 223.85 | |
| Year Low: | 157.25 | Year High: | 223.85 | |
| Price Avg 50: | 206.66 | Price Avg 200: | 186.54 | |
| Volume: | 667414 | Average Volume: | 769215 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeIEX full analysis
Welcome to MARKETSNAP’s SWOT analysis for Idex Corporation, or IEX as it’s known on the ticker. If you’re not familiar with Idex, let me give you the quick rundown. This company operates in the industrial machinery space, part of the broader industrials sector, and they’re known for their specialized engineering solutions, particularly in fluid and metering technologies, health and science technologies, and fire and safety products. With a solid market cap and a global presence, they’ve carved out a niche…
